Sanofi-GSK COVID-19 vaccine effective on Omicron variant

The part-French, part-British pharmaceutical collaboration — Sanofi-GSK — announced on Friday that their COVID-19 vaccine has been successfully tested against the Omicron variant of the Coronavirus.   The effectiveness of the protein-based vaccine against Omicron is around 72 per cent…